产时羊膜腔灌注减少胎粪污染羊水患者的胎粪吸入综合征并改善新生儿结局:一项系统综述与Meta分析
该系统综述与Meta分析纳入24项随机对照试验、共5994名产时中度至重度胎粪污染羊水的患者,评估预防性经宫颈羊膜腔灌注对胎粪吸入综合征及不良新生儿和母亲结局的影响。结果显示羊膜腔灌注组胎粪吸入综合征的合并比值比为0.33(95%CI 0.21-0.51),降低67%;除产后子宫内膜炎外,所有次要结局均显著降低。结论认为产时羊膜腔灌注可显著降低胎粪吸入综合征及其他不良新生儿结局的比值比。
要点
- 产时羊膜腔灌注使胎粪吸入综合征的合并比值比为0.33(95%CI 0.21-0.51),降低67%。
- 除产后子宫内膜炎外,羊膜腔灌注与所有次要新生儿和母亲结局的显著降低相关。
- 该系统综述与Meta分析纳入24项随机对照试验,共5994名参与者。
核心结论
- 产时羊膜腔灌注在胎粪污染羊水情况下显著降低胎粪吸入综合征的比值比及其他不良新生儿结局。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Embase、Web of Science和Scopus数据库及灰色文献来源,从建库至2021年11月。
- 纳入24项随机对照试验,共5994名产时中度至重度胎粪污染羊水的患者。
- 由2名评价者独立提取数据,采用改良Jadad评分评估研究质量。
主要发现
- 羊膜腔灌注组胎粪吸入综合征的合并比值比为0.33(95%CI 0.21-0.51),降低67%。
- 除产后子宫内膜炎外,羊膜腔灌注与所有次要结局的显著降低相关。
关键数值与推荐
- 主要结局为胎粪吸入综合征。
- 次要结局包括脐带以下胎粪、5分钟Apgar评分<7分、新生儿酸中毒、剖宫产、因胎心率异常行剖宫产、新生儿重症监护室入住和产后子宫内膜炎。
- 分类结局计算比值比及95%置信区间,连续结局计算加权均数差及95%置信区间。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to reassess the effect of prophylactic transcervical amnioinfusion for intrapartum meconium-stained amniotic fluid on meconium aspiration syndrome and other adverse neonatal and maternal outcomes. DATA SOURCES: From inception to November 2021, a systematic search of the literature was performed in PubMed, Embase, Web of Science, and Scopus databases and gray literature sources. STUDY ELIGIBILITY CRITERIA: We identified randomized controlled trials of patients with intrapartum moderate to thick meconium-stained amniotic fluid that evaluated the effect of amnioinfusion on adverse neonatal and maternal outcomes. METHODS: Of note, 2 reviewers independently abstracted data and gauged study quality by assigning a modified Jadad score. Meconium aspiration syndrome constituted the primary outcome. The secondary outcomes were meconium below the cords, Apgar scores of <7 at 5 minutes, neonatal acidosis, cesarean delivery, cesarean delivery for fetal heart rate abnormalities, neonatal intensive care unit admission, and postpartum endometritis. This study calculated the odds ratios with 95% confidence intervals for categorical outcomes and weighted mean differences with 95% confidence intervals for continuous outcomes. RESULTS: A total of 24 randomized studies with 5994 participants met the inclusion criteria. The overall odds of meconium aspiration syndrome was reduced by 67% in the amnioinfusion group (pooled odds ratio, 0.33; 95% confidence interval, 0.21-0.51). Except for postpartum endometritis, amnioinfusion was associated with a significant reduction in all secondary outcomes. CONCLUSION: Our study found that the use of intrapartum amnioinfusion in the setting of meconium-stained amniotic fluid significantly reduces the odds of meconium aspiration syndrome and other adverse neonatal outcomes.
引用
- Davis JD, Sanchez-Ramos L, McKinney JA, et al. Intrapartum amnioinfusion reduces meconium aspiration syndrome and improves neonatal outcomes in patients with meconium-stained fluid: a systematic review and meta-analysis. Am J Obstet Gynecol. 2023. PMID: 37164492. doi:10.1016/j.ajog.2022.07.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。